Clinical trial technology isn’t the barrier to interoperability; the economics are. Two industry leaders explain why nothing forces systems to connect.
- What AI Can't Fix In Decentralized Clinical Trial Data
- Decentralized Trials Promised Less Burden. Did They Deliver?
- Wireless Connectivity Is A Data Integrity Issue, Not IT
- Why Clinical AI Validation Needs Portability Testing Beyond A Single Accuracy Score
- The Synchronization Problem Clinical Research Isn't Watching
- Why Ophthalmology Trials Are Clinical Research's Toughest Tech Test
- Why Trustworthy Clinical Trial Data Starts As Analog, Not Digital
- Why Clinical Trial Coordinators Are Still The Human API
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Why Scalable EDC Systems Matter In Global Pharmaceutical Trials
Sponsors who treat EDC as core infrastructure—not just software—are best positioned to succeed globally. Explore how EDC platforms keep studies compliant while enabling flexibility.
-
What Is ePRO?
Real-time patient reporting improves data quality and trial insight. Digital tools cut missing data, enable remote participation, and clarify how treatments affect daily life.
-
Unlocking Potential AI And ML In Pharmacovigilance
Artificial intelligence (AI) and machine learning (ML) hold transformative potential in pharmacovigilance (PV), with the ability to enhance the efficiency, accuracy, and timeliness of drug safety monitoring.
-
Taking eCOA Technology Deployment Off The Critical Path
Consider this expedited review approach to facilitate the efficient evaluation of COAs and eCOAs, streamlining the pathway for successful trial execution.
-
3 Study Areas Where Your IRT Vendor Should Do More
Find out how advanced IRT systems now support diverse trial designs and how the expertise of RTSM vendors is crucial for tailoring solutions to trial needs and providing ongoing support.
-
Database To Advance Patient-Focused Drug Development With DHTs
Uncover how the Patient-Focused Digital Measure Report Database resource will leverage patient-reported data to highlight specific indications where DHTs can provide meaningful, patient-centric measures.
-
Emerging Biopharm Rapidly Sets Up Phase 1 Oncology Trial
Uncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.
-
How AI Activates The Full Potential Of Wearables In Clinical Research
Wearables provide continuous real‑world insights, and AI turns raw sensor data into meaningful evidence. With unified data infrastructure, studies gain more reliable, patient‑centered endpoints.
-
What Patients Are Asking For In Clinical Trials
Global insights show how travel demands, uneven compensation, and overlooked caregiver burden undermine trial participation — making flexible, patient-centered approaches essential.
-
Patient Recruitment From A Site Perspective
When used strategically and in conjunction with traditional enrollment methods, see how technology can significantly enhance patient recruitment efforts.
RECENT NEWSLETTERS
- 08.27.26 -- Patient Data Breaks Down When Trial Systems Miss Reality
- 08.20.26 -- Clinical AI Validation, Trial Handoffs, And Smarter Study Builds
- 08.13.26 -- AI Urgency, Site-Sponsor Gaps, And Data That Saves Lives
- 08.06.26 -- Clinical Trial Tech: AI, Data Quality, And Faster Study Build
- 08.01.26 -- July's Top Clinical Trial Tech Reads